Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04671823Unknown

Changes in the Prevalence of Oncogenic HPV Types

Role: lead

NCT00846716Not ApplicableUnknown

Shiga Progression of Diabetes, Nephropathy and Retinopathy

Role: collaborator

NCT00448526Not ApplicableTerminated

Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy

Role: lead

All 3 trials loaded